Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 33

1.

Ascertainment of cause-specific mortality in COPD: operations of the TORCH Clinical Endpoint Committee.

McGarvey LP, John M, Anderson JA, Zvarich M, Wise RA; TORCH Clinical Endpoint Committee..

Thorax. 2007 May;62(5):411-5.

2.

The impact of inhaled corticosteroid and long-acting beta-agonist combination therapy on outcomes in COPD.

Hanania NA.

Pulm Pharmacol Ther. 2008;21(3):540-50. doi: 10.1016/j.pupt.2007.12.004. Review.

PMID:
18280761
3.

Combination inhaled steroid and long-acting beta2-agonist versus tiotropium for chronic obstructive pulmonary disease.

Welsh EJ, Cates CJ, Poole P.

Cochrane Database Syst Rev. 2013 May 31;(5):CD007891. doi: 10.1002/14651858.CD007891.pub3. Review.

PMID:
23728670
4.

Inhaled steroids and risk of pneumonia for chronic obstructive pulmonary disease.

Kew KM, Seniukovich A.

Cochrane Database Syst Rev. 2014 Mar 10;(3):CD010115. doi: 10.1002/14651858.CD010115.pub2. Review.

PMID:
24615270
5.

Combination inhaled steroid and long-acting beta2-agonist versus tiotropium for chronic obstructive pulmonary disease.

Welsh EJ, Cates CJ, Poole P.

Cochrane Database Syst Rev. 2010 May 12;(5):CD007891. doi: 10.1002/14651858.CD007891.pub2. Review. Update in: Cochrane Database Syst Rev. 2013;5:CD007891.

PMID:
20464758
6.

A systematic review of the cardiovascular risk of inhaled anticholinergics in patients with COPD.

Hilleman DE, Malesker MA, Morrow LE, Schuller D.

Int J Chron Obstruct Pulmon Dis. 2009;4:253-63. Review.

7.

Combined corticosteroid and long-acting beta₂-agonist in one inhaler versus placebo for chronic obstructive pulmonary disease.

Nannini LJ, Poole P, Milan SJ, Holmes R, Normansell R.

Cochrane Database Syst Rev. 2013 Nov 10;(11):CD003794. doi: 10.1002/14651858.CD003794.pub4. Review.

PMID:
24214176
8.
10.

Tiotropium bromide. A review of its use as maintenance therapy in patients with COPD.

Keam SJ, Keating GM.

Treat Respir Med. 2004;3(4):247-68. Review.

PMID:
15350163
11.

Pharmacotherapy for mortality reduction in chronic obstructive pulmonary disease.

Sin DD, Man SF.

Proc Am Thorac Soc. 2006 Sep;3(7):624-9. Review.

PMID:
16963545
12.

Mortality in COPD: causes, risk factors, and prevention.

Berry CE, Wise RA.

COPD. 2010 Oct;7(5):375-82. doi: 10.3109/15412555.2010.510160. Review.

PMID:
20854053
13.

Combined corticosteroid and long-acting beta(2)-agonist in one inhaler versus inhaled corticosteroids alone for chronic obstructive pulmonary disease.

Nannini LJ, Poole P, Milan SJ, Kesterton A.

Cochrane Database Syst Rev. 2013 Aug 30;(8):CD006826. doi: 10.1002/14651858.CD006826.pub2. Review.

PMID:
23990350
14.

Long-acting inhaled therapy (beta-agonists, anticholinergics and steroids) for COPD: a network meta-analysis.

Kew KM, Dias S, Cates CJ.

Cochrane Database Syst Rev. 2014 Mar 26;(3):CD010844. doi: 10.1002/14651858.CD010844.pub2. Review.

PMID:
24671923
15.
16.
17.

Tiotropium versus long-acting beta-agonists for stable chronic obstructive pulmonary disease.

Chong J, Karner C, Poole P.

Cochrane Database Syst Rev. 2012 Sep 12;(9):CD009157. doi: 10.1002/14651858.CD009157.pub2. Review.

PMID:
22972134
18.
19.

Combined corticosteroid and long-acting beta(2)-agonist in one inhaler versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease.

Nannini LJ, Lasserson TJ, Poole P.

Cochrane Database Syst Rev. 2012 Sep 12;(9):CD006829. doi: 10.1002/14651858.CD006829.pub2. Review.

20.

Insights into interventions in managing COPD patients: lessons from the TORCH and UPLIFT studies.

Miravitlles M, Anzueto A.

Int J Chron Obstruct Pulmon Dis. 2009;4:185-201. Review.

Supplemental Content

Support Center